Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Mometasone/Formoterol vs Monotherapy in Persistent Asthma
NCT00383240Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2006
- Primary completion
- Sep 2008
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of mometasone in asthma (4 arms), sponsored by Organon & Co. Primary endpoints: Area Under the Curve From 0 to 12 Hours of the Change From Baseline in Forced Expiratory Volume in One Second and Time-to-First Severe Asthma Exacerbation at 26 weeks. Started Sep 2006; status: completed.
02
Drugs
mometasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00383240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383240.